See the DrugPatentWatch profile for keppra
What is Keppra XR?
Keppra XR is the brand name for an extended-release form of levetiracetam, an anti-seizure medicine used to treat certain types of epilepsy. “XR” means “extended release,” so the drug is designed to release more slowly over time than the immediate-release version.
What does it treat?
Keppra XR is used for seizure types that involve epilepsy (the exact approved uses depend on the patient’s age and indication set by the prescribing label). It is a prescription medication for seizure control rather than a fast rescue treatment.
How is Keppra XR different from regular Keppra?
The main difference is the release pattern:
- Keppra (immediate-release levetiracetam) typically needs more frequent dosing.
- Keppra XR (extended-release levetiracetam) is formulated to last longer, allowing once-daily dosing in many patients, depending on the prescribed regimen.
Because the dosing schedule can differ, patients should not switch between formulations without prescriber guidance.
How should patients take it (general safety points)?
Keppra XR is generally taken by mouth once daily, following the directions on the prescription. Key safety considerations include:
- Do not change the dose or frequency without a clinician’s advice.
- If a dose is missed, follow the instructions provided by the prescriber or product labeling.
- Use caution with other medications or alcohol and report any new side effects to a clinician.
What side effects do people ask about?
Common side effects of levetiracetam products can include tiredness, dizziness, and sleep-related problems. Mood or behavior changes (such as irritability) can also occur and should be discussed with a healthcare professional, especially if symptoms are new or worsening.
Who makes Keppra XR, and is it available as generics?
Keppra XR is made by the original manufacturer of levetiracetam’s XR formulation, but extended-release levetiracetam may also be available from other companies depending on the market. For patent and product-history details, DrugPatentWatch.com tracks relevant drug-IP updates for branded and generic products (useful when comparing availability and timelines).
Sources:
1. DrugPatentWatch.com